뒤로
VISEN Pharmaceuticals(02561.HK) 가격
02561.HK 주가 차트
VISEN PHARMA-B (02561.HK)
VISEN Pharmaceuticals
HK$34.1
3.33%
$1.1
장 종료: Feb 16, 12:00:00 HKT
주요 통계
이전 종가
$33.38
시가
$33
일일 범위
$33 - $34.16
52주 범위
$29.06 - $69.15
거래량
--
평균 거래량
33.2K
EPS(TTM)
-2.11
배당수익률
--
시가총액
$3.8B
VISEN PHARMA-B란 무엇인가요?
VISEN Pharmaceuticals operates as a biopharmaceutical company. The company is headquartered in Suzhou, Jiangsu and currently employs 54 full-time employees. The company went IPO on 2025-03-21. The firm's main products under development include lonapegsomatropin, navepegritide, and palopegteriparatide. The lonapegsomatropin is used to treat growth hormone deficiency in children aged 3 to 17 years old. The navepegritide is a disease repair therapy used to treat children with cartilage dysplasia aged 2 to 10 years old. The palopegteriparatide is a treatment method used to treat adult hypoparathyroidism. The firm is in the late stage of research and development, and its products are close to commercialization.